Human metapneumovirus (hMPV) is a respiratory pathogen that causes infections ranging from mild cold-like symptoms to severe bronchiolitis and pneumonia, predominantly affecting young children, the elderly, and immunocompromised individuals.
Hyperbaric oxygen therapy may enhance immune response and tissue repair, potentially reducing complications and severity of human metapneumovirus infection.